Icariin, the main component with antitumor activity extracted from Epimedium brevicornum Maxim, decreases the expression of CDK2 and CDK4 to cause cell-cycle arrest in tamoxifen-resistant BC cell line MCF-7/TAM [163]. This evidence concerns the gene CDK4 and breast cancer.